SecBot SecBot
SECBOTREPLAY Home › Report › UTHR

UTHR · CEO Martine Rothblatt executed a large derivative exercise of 9,500…

UNITED THERAPEUTICS Corp · CLUSTER filed Aug 28, 2026 at 16:30 ET

At the news

NEUTRALIMPACT 2/10

CLUSTER filed Aug 28, 2026 at 16:30 ET

CEO Martine Rothblatt executed a large derivative exercise of 9,500 shares at $135.42, then immediately sold the resulting shares plus additional holdings in 20 open-market transactions on August 27, 2026, totaling ~$5.9M in sales. EVP & General Counsel Paul Mahon also sold 120 shares for $63K on August 20. The CEO's sales are consistent with a cashless exercise-and-sell pattern (tax withholding and liquidity), not a directional bearish signal. At $22.6B market cap, the total open-market sales of ~$316K (cluster) represent ~0.0014% of market cap, trivial and routine.

  • CEO Martine Rothblatt exercised 9,500 derivative shares at $135.42 ($1.29M intrinsic value) and sold a total of ~11,000 shares across 20 trades on Aug 27, 2026, netting ~$5.9M in proceeds
  • EVP & General Counsel Paul Mahon sold 120 shares for ~$63K on Aug 20, 2026
  • Total open-market sales in the cluster: ~$316K, representing ~0.0014% of $22.6B market cap
  • The CEO's sales are consistent with a cashless exercise-and-sell pattern, not a directional bearish signal

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access